Stock Story -
What Happened?
Shares of automation software company UiPath (NYSE:PATH) jumped 7.9% in the morning session after market optimism around innovators in the software as a service (SaaS) space continued to improve following strong earnings from Salesforce. The enterprise software giant showcased clear progress in capturing demand for AI solutions, signing 200 deals within a week of launching Agentforce, its new AI platform for enterprise customers. In addition, Salesforce reported thousands more deals in the pipeline, hinting at robust future growth.Reviewing some of the numbers, Salesforce reported sales and adjusted operating income ahead of Wall Street's expectations. On the other hand, EPS and some top-line growth indicators, including billings and remaining performance obligations (RPO), fell slightly below consensus estimates, as products like Tableau, MuleSoft, and Slack revealed some weaknesses. Despite the mixed top-line result, CRM recorded double-digit growth in the Sales and Service Cloud segments, which is encouraging.
Since the onset of the AI boom, Wall Street has been craving hard data to justify the lofty projections surrounding the industry's potential. The numbers are finally trickling in, and the data suggest the AI market's trajectory might exceed initial expectations, heralding the shift from speculative hype to tangible value creation.
Is now the time to buy UiPath? Find out by reading the original article on StockStory, it’s free.
What The Market Is Telling Us
UiPath’s shares are quite volatile and have had 18 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.The biggest move we wrote about over the last year was 6 months ago when the stock dropped 35.1% on the news that the company reported first-quarter results and lowered its full-year revenue guidance, falling significantly short of Wall Street's expectations. The company noted it saw "increased deal scrutiny and lengthening sales cycles for large multi-year deals."
In addition, it observed growth deceleration in the second half of March and into April due to a challenging macroeconomic environment and a change in customer behavior, which likely drove the weak guidance. Lastly, the company said that the investments made to reaccelerate growth fell short of expectations, making it less nimble when responding to customer needs, and created short-term pressure on operating margins.
Furthermore, CEO Rob Enslin unexpectedly resigned.
Following the disappointing results, multiple Wall Street analysts downgraded the stock's rating. For example, Bank of America (NYSE:BAC) downgraded the stock from Buy to Neutral and lowered the price target from $30 to $16, highlighting the weakening conviction in the near term given the execution and growth challenges.
Overall, this was a weak quarter for the company, providing little reason for investors to stay positive.
UiPath is down 35.7% since the beginning of the year, and at $15.31 per share, it is trading 43.1% below its 52-week high of $26.88 from February 2024. Investors who bought $1,000 worth of UiPath’s shares at the IPO in April 2021 would now be looking at an investment worth $221.81.